Tech Company Financing Transactions
LatchBio Funding Round
LatchBio, based in San Francisco, secured $28 million in investment from Coatue Management, Lux Capital and Caffeinated Capital.
Transaction Overview
Company Name
Announced On
6/2/2022
Transaction Type
Venture Equity
Amount
$28,000,000
Round
Series A
Investors
Coatue Management (Lead Investor) (David Cahn)
Lux Capital (Lead Investor) (Brandon Reeves)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Undisclosed
San Francisco, CA 94103
USA
San Francisco, CA 94103
USA
Phone
Undisclosed
Website
Email Address
Overview
The convergence of laboratory automation, high-throughput assays, and machine learning is moving the medium of biological discovery to silicon. Bench top experimentation will be the machine code of the biological programmer, simple instructions that are executed by robotics just as bytes are fed through a compiler.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alfredo Andere
Chief Operating Officer
Kyle Giffin
Chief Technical Officer
Kenny Workman
Browse more venture capital transactions:
Prev: 6/2/2022: RealWear venture capital transaction
Next: 6/2/2022: Felux venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. VC investment data records reported here come from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs